G
Gemini Therapeutics Inc
NASDAQ:GMTX
Gemini Therapeutics Inc
NASDAQ:GMTX
Price:
19.89 USD
47.33%
Market Closed
Updated:
May 14, 2024
Balance Sheet
Balance Sheet Decomposition
Gemini Therapeutics Inc
Gemini Therapeutics Inc
| Current Assets | 198.5m |
| Cash & Short-Term Investments | 194.6m |
| Other Current Assets | 3.9m |
| Non-Current Assets | 1.7m |
| PP&E | 1.6m |
| Other Non-Current Assets | 116k |
| Current Liabilities | 22.6m |
| Accounts Payable | 16.2m |
| Accrued Liabilities | 6.4m |
| Non-Current Liabilities | 1m |
| Other Non-Current Liabilities | 1m |
Balance Sheet
Gemini Therapeutics Inc
Gemini Therapeutics Inc
Currency: USD
| Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
1
|
137
|
195
|
|
| Cash |
1
|
0
|
0
|
|
| Cash Equivalents |
0
|
137
|
195
|
|
| Other Current Assets |
0
|
3
|
4
|
|
| Total Current Assets |
1
|
140
|
198
|
|
| PP&E Net |
0
|
0
|
2
|
|
| PP&E Gross |
0
|
0
|
2
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
|
| Other Long-Term Assets |
121
|
0
|
0
|
|
| Total Assets |
122
N/A
|
140
+15%
|
200
+43%
|
|
| Liabilities | ||||
| Accounts Payable |
0
|
3
|
16
|
|
| Accrued Liabilities |
0
|
7
|
6
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
5
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
15
|
23
|
|
| Long-Term Debt |
0
|
0
|
0
|
|
| Other Liabilities |
4
|
0
|
1
|
|
| Total Liabilities |
5
N/A
|
16
+223%
|
24
+51%
|
|
| Equity | ||||
| Common Stock |
112
|
0
|
0
|
|
| Retained Earnings |
1
|
185
|
112
|
|
| Additional Paid In Capital |
6
|
310
|
289
|
|
| Total Equity |
117
N/A
|
125
+6%
|
177
+41%
|
|
| Total Liabilities & Equity |
122
N/A
|
140
+15%
|
200
+43%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
4
|
4
|
17
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
